Kurs
+1,39%
Kurs
+1,39%
Open
7,24
High
7,30
Low
7,22
Close
7,30
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Likviditet
0,51 MNOK
Likviditet
0,51 MNOK
Rel. mcap
0,12%
Antal aktier
70 384
Likviditet under dagen för detta pressmeddelande
Kalender
Tid* | ||
2026-02-19 | 08:00 | Bokslutskommuniké 2025 |
2025-11-06 | 08:00 | Kvartalsrapport 2025-Q3 |
2025-08-26 | 08:00 | Kvartalsrapport 2025-Q2 |
2025-05-13 | N/A | Årsstämma |
2025-05-07 | 08:00 | Kvartalsrapport 2025-Q1 |
2025-02-20 | 08:00 | Bokslutskommuniké 2024 |
2024-11-20 | - | Extra Bolagsstämma 2024 |
2024-11-07 | - | Kvartalsrapport 2024-Q3 |
2024-08-26 | - | Kvartalsrapport 2024-Q2 |
2024-05-15 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
2024-05-14 | - | Årsstämma |
2024-05-08 | - | Kvartalsrapport 2024-Q1 |
2024-02-15 | - | Bokslutskommuniké 2023 |
2023-11-02 | - | X-dag halvårsutdelning CONTX 0.15741 |
2023-10-26 | - | Kvartalsrapport 2023-Q3 |
2023-08-24 | - | Kvartalsrapport 2023-Q2 |
2023-05-08 | - | X-dag halvårsutdelning CONTX 0.15741 |
2023-05-05 | - | X-dag halvårsutdelning CONTX 0.15645 |
2023-05-03 | - | Årsstämma |
2023-04-27 | - | Kvartalsrapport 2023-Q1 |
2023-02-16 | - | Bokslutskommuniké 2022 |
2022-10-20 | - | Kvartalsrapport 2022-Q3 |
2022-08-11 | - | Kvartalsrapport 2022-Q2 |
2022-05-05 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
2022-05-04 | - | Årsstämma |
2022-04-21 | - | Kvartalsrapport 2022-Q1 |
2022-02-17 | - | Bokslutskommuniké 2021 |
2021-12-10 | - | Extra Bolagsstämma 2021 |
2021-10-21 | - | Kvartalsrapport 2021-Q3 |
2021-08-12 | - | Kvartalsrapport 2021-Q2 |
2021-05-06 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
2021-05-05 | - | Årsstämma |
2021-04-22 | - | Kvartalsrapport 2021-Q1 |
2021-02-18 | - | Bokslutskommuniké 2020 |
2020-10-22 | - | Kvartalsrapport 2020-Q3 |
2020-08-19 | - | Split CONTX 1:10 |
2020-08-13 | - | Kvartalsrapport 2020-Q2 |
2020-08-05 | - | Extra Bolagsstämma 2020 |
2020-05-07 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
2020-05-06 | - | Årsstämma |
2020-04-23 | - | Kvartalsrapport 2020-Q1 |
2020-02-20 | - | Bokslutskommuniké 2019 |
2019-10-24 | - | Kvartalsrapport 2019-Q3 |
2019-08-15 | - | Kvartalsrapport 2019-Q2 |
2019-05-09 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
2019-05-08 | - | Årsstämma |
2019-04-25 | - | Kvartalsrapport 2019-Q1 |
2019-02-21 | - | Bokslutskommuniké 2018 |
2018-10-25 | - | Kvartalsrapport 2018-Q3 |
2018-08-16 | - | Kvartalsrapport 2018-Q2 |
2018-05-11 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
2018-05-09 | - | Årsstämma |
2018-04-26 | - | Kvartalsrapport 2018-Q1 |
2018-02-22 | - | Bokslutskommuniké 2017 |
2017-10-26 | - | Kvartalsrapport 2017-Q3 |
2017-08-17 | - | Kvartalsrapport 2017-Q2 |
2017-05-11 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
2017-05-10 | - | Årsstämma |
2017-04-27 | - | Kvartalsrapport 2017-Q1 |
2017-02-23 | - | Bokslutskommuniké 2016 |
2016-10-27 | - | Kvartalsrapport 2016-Q3 |
2016-08-18 | - | Kvartalsrapport 2016-Q2 |
2016-04-21 | - | Kvartalsrapport 2016-Q1 |
2016-04-21 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
2016-04-20 | - | Årsstämma |
2016-02-18 | - | Bokslutskommuniké 2015 |
2015-10-22 | - | Kvartalsrapport 2015-Q3 |
2015-08-20 | - | Kvartalsrapport 2015-Q2 |
2015-04-23 | - | Kvartalsrapport 2015-Q1 |
2015-04-23 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
2015-04-22 | - | Årsstämma |
2015-02-19 | - | Bokslutskommuniké 2014 |
2014-10-23 | - | Kvartalsrapport 2014-Q3 |
2014-08-21 | - | Kvartalsrapport 2014-Q2 |
2014-05-12 | - | 15-7 2014 |
2014-04-24 | - | Kvartalsrapport 2014-Q1 |
2014-04-24 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
2014-04-23 | - | Årsstämma |
2014-02-20 | - | Bokslutskommuniké 2013 |
2013-10-24 | - | Kvartalsrapport 2013-Q3 |
2013-08-22 | - | Kvartalsrapport 2013-Q2 |
2013-06-13 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
2013-06-12 | - | Årsstämma |
2013-04-25 | - | Kvartalsrapport 2013-Q1 |
2013-02-21 | - | Bokslutskommuniké 2012 |
2012-10-25 | - | Kvartalsrapport 2012-Q3 |
2012-08-23 | - | Kvartalsrapport 2012-Q2 |
2012-06-14 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
2012-06-13 | - | Årsstämma |
2012-04-26 | - | Kvartalsrapport 2012-Q1 |
2012-02-23 | - | Bokslutskommuniké 2011 |
2011-10-27 | - | Kvartalsrapport 2011-Q3 |
2011-08-25 | - | Kvartalsrapport 2011-Q2 |
2011-06-10 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
2011-06-09 | - | Årsstämma |
2011-04-28 | - | Kvartalsrapport 2011-Q1 |
2011-02-17 | - | Bokslutskommuniké 2010 |
2010-10-21 | - | Kvartalsrapport 2010-Q3 |
2010-08-19 | - | Kvartalsrapport 2010-Q2 |
2010-06-04 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
2010-06-03 | - | Årsstämma |
2010-04-21 | - | Kvartalsrapport 2010-Q1 |
2010-02-18 | - | Bokslutskommuniké 2009 |
2009-10-22 | - | Kvartalsrapport 2009-Q3 |
2009-08-20 | - | Kvartalsrapport 2009-Q2 |
2009-04-23 | - | Kvartalsrapport 2009-Q1 |
2008-06-06 | - | X-dag ordinarie utdelning CONTX 1.50 NOK |
Beskrivning
Land | Sverige |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Medicinteknik |
2023-11-21 08:00:14
STOCKHOLM, SWEDEN / November 20, 2023 / At this year's RSNA in Chicago, November
26-30, ContextVision puts their success story Altumira in the spotlight - adding
new, impressive features to an already exceptional image enhancement solution.
ContextVision offers solutions for ultrasound, X-ray and MRI. With a core
business focus on image enhancement software designed to deliver unprecedented
image quality, ContextVision is the global market leader and partner to leading
OEMs, with solutions installed worldwide in more than 450,000 systems. Thanks to
its superior imaging quality, ContextVision's technology leads to more rapid and
confident diagnoses.
One of ContextVision's most successful solutions is Altumira, a powerful
software that draws on advanced AI to take digital X-ray images to a whole new
level. Designed to address the many challenges of static and dynamic digital
radiography, Altumira combines ContextVision's world-leading image enhancement
technology with the latest breakthroughs in deep learning.
This year's RSNA sees the unveiling of updated versions of Altumira and Altumira
Plus
Altumira now features impressive scatter correction functionality, for
exceptional quality in images acquired without a physical grid. Powered by AI,
the scatter correction feature offers flexible and efficient contrast, detail,
and noise control. This in turn enables improved workflow, enhanced efficiency,
and a lower X-ray dose compared to images acquired with a grid.
Altumira Plus - for dynamic imaging - will be upgraded with improved noise
suppression and enhanced visualization of details, e.g., stents and vessels.
These new features add value to interventional cardiovascular procedures
performed with mobile c-arms and angiography systems.
Meet ContextVision at RSNA in booth #6802
ContextVision will be demonstrating the new Altumira features at RSNA 2023. Join
them at Booth #6802, North Hall, Level 3. For more info, contact William
McGinnis, Sales Director Americas, william.mcginnis@contextvision.com or visit
www.contextvision.com.
About ContextVision
ContextVision is a medical technology software company specialized in image
analysis and artificial intelligence. As the global market leader within image
enhancement, we are a trusted partner to leading manufacturers of ultrasound, X-
ray and MRI equipment around the world. Our expertise is to develop powerful
software products, based on proprietary technology and artificial intelligence
for image-based applications. The company's cutting-edge technology helps
clinicians accurately interpret medical images, a crucial foundation for better
diagnosis and treatment. The company, established in 1983, is based in Sweden
with local representation in the U.S., Japan, China, and Korea. ContextVision is
listed on the Oslo Stock Exchange under the ticker CONTX.